Apigenin
Botanical source: Matricaria Recutita
Chemical Name: 5, 7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
Cas No.: 520-36-5
Molecular Formula: C15H10O5
Molecular Weight: 270.2
Specification:
Apigenin 1.2%, 3%, 90%, 95%, 98%; tested by HPLC
Features of Skyherb’s Apigenin
1. 100% naturally derived from Chamomile flower;
2. High purity and large production capacity;
3. Non-Irradiated;
4. Kosher certified.
Packing:
25kgs/drum, 5kgs/drum or 1kg/bag
Description:
Apigenin is one of a bioflavonoid found in leafy plants and vegetables (e.g. parsley, celery, chamomile, thyme).
Function:
Like most flavonoids, Apigenin has anti-inflammatory, anti-tumor, anti-spasmodic properties, and acts as an antioxidant. It is the subject of intensive research for its biological properties. The most widespread research has been for its potential to fight cancer.
There have been epidemiological studies correlating the consumption of this compound with lowered cancer rates. Also, there have been a number of studies examining the effect of this flavonoid on cell lines of various types of cancers. There have also been several studies examining its effect when combined with chemotherapy agents.
One large study correlated Apigenin consumption, along with other flavonoids, with a lowered risk of breast cancer. More recently, its consumption by women was found to lower the risk of ovarian cancer. This finding was specific for Apigenin, and did not apply to other flavonoids in the study. It has also been found to inhibit the growth of several types of cancer lines. These include those in colon, breast, thyroid, skin, leukemia, and pancreas cells.
There have been mixed results when the effects of ingesting Apigenin were examined for its effects on chemotherapy agents. These are chemicals that are used to kill cancer cells, although many of the cells remain resistant to the chemicals. In a study that utilized leukemia cells, this flavonoid reduced the toxicity of the chemotherapy agent, doxorubicin. That suggests that consuming Apigenin would increase the severity of leukemia being treated with this agent.